Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Premium

Profit Triples for Ramelius Resources (ASX:RMS) in H1 FY25 Amid Record Gold Output, Upgrades FY25 Outlook

Ramelius Resources Ltd (ASX:RMS) is a leading Western Australian gold producer and has reported encouraging numbers in the first half of fiscal year 2025 (H1 FY25). The company’s results were driven by high-grade ore production, operational efficiency, and elevated gold prices. Furthermore, on the …

Team Kalkine | 30 April 2025

Integral Diagnostics (ASX:IDX) Eyes Growth on Capitol Merger, MRI Deregulation & Screening Initiatives

Integral Diagnostics Limited (ASX:IDX) is an ASX-listed company that offers medical imaging services across Australia and New Zealand. In the first half of the financial year 2025 (H1FY25), the company recorded an 8% YoY revenue increase to AUD 249.4 million, supported by continued organic …

Team Kalkine | 29 April 2025

NEXTDC (ASX:NXT) Reports 12.5% Revenue Growth in H1 FY25, Targets AUD 340–350Mn Revenue in FY25

NEXTDC Limited (ASX:NXT) is an ASX-listed Data Centre-as-a-Service provider delivering critical power, security and connectivity solutions to global cloud platforms, enterprises, and government clients across Australia.

Team Kalkine | 24 April 2025

Pro Medicus (ASX:PME) Expands Global Footprint with UCSF Partnership, Shares Optimistic Outlook

Melbourne-based health informatics firm Pro Medicus Limited (ASX:PME) offers a full range of medical imaging, software, and services to healthcare groups, hospitals and imaging centres. The company has a presence across Europe, North America and Australia. In the six months ended 31 December 2024 …

Team Kalkine | 23 April 2025

Life360 Inc. (ASX:360) Accelerates in FY24 With 121% EBITDA Jump, Eyes New Product Launch

Life360 Inc. (ASX:360) is a provider of location-based tracking and messaging solutions for safety and coordination. In the full year ended 31 December 2024 (FY24), the company posted a 22% YoY increase in total revenue, reaching USD 371.5 million, up from USD 304.5 million …

Team Kalkine | 16 April 2025

Arafura Rare Earths (ASX:ARU) narrowed losses in 1HFY25, secures offtake for Nolan project production

Arafura Rare Earths Limited (ASX:ARU) is an Australian mineral exploration and development company that continues to cement its role in the rare earths sector through focused development of its Nolans Project in the Northern Territory.

Team Kalkine | 14 April 2025

Understanding Smart ETFs: Benefits, Risks, and a Diverse Range of Options

Exchange Traded Funds (ETFs) are a convenient way to start building a balanced portfolio and it's no surprise that they are among the fastest-growing investment products worldwide.

Team Kalkine | 11 April 2025

Neuren Pharmaceuticals (ASX:NEU) FY24 Revenue Hits AUD 213M Driven by U.S. DAYBUE™ Sales, Plans Global expansion

Neuren Pharmaceuticals Limited (ASX:NEU) is an ASX-listed biopharmaceutical company, focusing on the development and commercialisation of novel treatments for neurological disorders. The company is making significant progress with its lead products, DAYBUE™ (trofinetide) and NNZ-2591.

Team Kalkine | 09 April 2025

Is the correction over in these five ASX stocks?

The S&P/ASX200 closed sharply higher on Tuesday, rising 166.70 points or 2.27% to 7,510.00, after hitting a new 52-week low on Monday after China retaliated against US tariffs. Today’s gains in the Australian equity benchmark were supported by broad-based buying across the sector, with …

Team Kalkine | 08 April 2025

Five ASX dividend stocks looking attractive after market correction

Following a recent sharp downturn in the Australian share market, marked by a nearly 5% drop in the ASX 200 within a week, investors are rethinking their strategies in search of resilience and reliable returns. The Australian share market offers several dividend-paying stocks for …

Team Kalkine | 08 April 2025
Support

Hi! How can we help you today?

Loading…